Eversept Partners, LP Dexcom Inc Transaction History

Eversept Partners, LP

  • $991 Million
  • Q4 2024

A detailed history of Eversept Partners, LP transactions in Dexcom Inc stock. As of the latest transaction made, Eversept Partners, LP holds 148,688 shares of DXCM stock, worth $10.1 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
148,688
Holding current value
$10.1 Million
% of portfolio
1.17%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$65.68 - $81.01 $9.77 Million - $12 Million
148,688 New
148,688 $11.6 Million
Q2 2022

Nov 08, 2023
SELL
$67.99 - $132.89 $947,508 - $1.85 Million
-13,936 Reduced 49.06%
14,468 $1.08 Million
Q2 2022

Aug 15, 2022
SELL
$67.99 - $132.89 $947,508 - $1.85 Million
-13,936 Reduced 49.06%
14,468 $1.08 Million
Q1 2022

Nov 08, 2023
BUY
$94.08 - $130.2 $2.67 Million - $3.7 Million
28,404 New
28,404 $3.63 Million
Q1 2022

May 16, 2022
BUY
$94.08 - $130.2 $2.07 Million - $2.86 Million
22,003 Added 343.74%
28,404 $14.5 Million
Q3 2021

Nov 08, 2023
SELL
$106.71 - $143.18 $333,362 - $447,294
-3,124 Reduced 32.8%
6,401 $875,000
Q3 2021

Nov 15, 2021
SELL
$106.71 - $143.18 $333,362 - $447,294
-3,124 Reduced 32.8%
6,401 $3.5 Million
Q2 2021

Nov 08, 2023
SELL
$80.99 - $107.93 $746,403 - $994,682
-9,216 Reduced 49.18%
9,525 $1.02 Million
Q2 2021

Aug 16, 2021
SELL
$80.99 - $107.93 $746,403 - $994,682
-9,216 Reduced 49.18%
9,525 $4.07 Million
Q1 2021

Nov 08, 2023
BUY
$84.79 - $104.74 $1.38 Million - $1.7 Million
16,268 Added 657.82%
18,741 $1.68 Million
Q1 2021

May 13, 2021
BUY
$84.79 - $104.74 $1.38 Million - $1.7 Million
16,268 Added 657.82%
18,741 $6.74 Million
Q4 2020

Nov 08, 2023
BUY
$78.0 - $104.5 $192,894 - $258,428
2,473 New
2,473 $228,000
Q4 2020

Feb 16, 2021
SELL
$78.0 - $104.5 $327,366 - $438,586
-4,197 Reduced 62.92%
2,473 $914,000
Q2 2020

Nov 08, 2023
SELL
$62.68 - $105.34 $806,503 - $1.36 Million
-12,867 Reduced 65.86%
6,670 $676,000
Q2 2020

Aug 13, 2020
SELL
$62.68 - $105.34 $806,503 - $1.36 Million
-12,867 Reduced 65.86%
6,670 $2.7 Million
Q1 2020

Nov 08, 2023
BUY
$47.79 - $75.63 $357,803 - $566,241
7,487 Added 62.13%
19,537 $1.32 Million
Q1 2020

May 13, 2020
BUY
$47.79 - $75.63 $357,803 - $566,241
7,487 Added 62.13%
19,537 $5.26 Million
Q4 2019

Nov 08, 2023
SELL
$36.62 - $57.29 $1.19 Million - $1.86 Million
-32,500 Reduced 72.95%
12,050 $659,000
Q4 2019

Feb 13, 2020
SELL
$36.62 - $57.29 $1.19 Million - $1.86 Million
-32,500 Reduced 72.95%
12,050 $2.64 Million
Q3 2019

Nov 08, 2023
BUY
$35.53 - $43.8 $1.58 Million - $1.95 Million
44,550 New
44,550 $1.66 Million
Q3 2019

Nov 13, 2019
BUY
$35.53 - $43.8 $1.58 Million - $1.95 Million
44,550 New
44,550 $6.65 Million

Others Institutions Holding DXCM

# of Institutions
1,084
Shares Held
352M
Call Options Held
8.45M
Put Options Held
5.75M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.2B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email